기본 정보
- CAS
159094-94-7- 표준 SMILES
O=C(O)C1=CCCN(CCON=C(c2ccccc2)c2ccccc2)C1- InChIKey
NGNALWDRPKNJGR-UHFFFAOYSA-N- 분자식
- C21H22N2O3
- 평균 분자량
- 350.4 g/mol
- 단동위원소 질량
- 350.16304257
개요
1-[2-[(diphenylmethylene)amino]oxyethyl]-3,6-dihydro-2H-pyridine-5-carboxylic acid is a diarylmethane.
이름 및 식별자
- 우선 이름
- NO 711
- IUPAC
- 1-[2-(benzhydrylideneamino)oxyethyl]-3,6-dihydro-2H-pyridine-5-carboxylic acid
- 영어명
- 3-Pyridinecarboxylic acid, 1-[2-[[(diphenylmethylene)amino]oxy]ethyl]-1,2,5,6-tetrahydro-
- 분자식
- C21H22N2O3
- 분자량
- 350.41
이름 및 동의어
159094-94-7NO-711BGU9MZ2G303-Pyridinecarboxylic acid, 1-(2-(((diphenylmethylene)amino)oxy)ethyl)-1,2,5,6-tetrahydro-DTXSID30166582NO 7113-Pyridinecarboxylic acid, 1-[2-[[(diphenylmethylene)amino]oxy]ethyl]-1,2,5,6-tetrahydro-RefChem:927846DTXCID9089073CHEMBL4731041-[2-(benzhydrylideneamino)oxyethyl]-3,6-dihydro-2H-pyridine-5-carboxylic acid1-(2-(((Diphenylmethylene)amino)oxy)ethyl)-1,2,5,6-tetrahydropyridine-3-carboxylic acid
이름 더 보기
CHEMBL5450501-(2-(((Diphenylmethylene)amino)oxy)ethyl)-1,2,5,6-tetrahydropyridine-3-carboxylicacidUNII-BGU9MZ2G30Tocris-1779Lopac-N-142Biomol-NT_000271Lopac0_000880BPBio1_000948
데이터베이스 식별자
- CAS
159094-94-7- PubChem CID
- 4515
- DTXSID
DTXSID30166582- ChEMBL
CHEMBL473104、CHEMBL545050- ChEBI
CHEBI:92744
물성
구조 계산 물성
- XLogP
- 1.5
- 극성 표면적
- 62.1 Ų
- 수소 결합 공여자 수
- 1
- 수소 결합 수용자 수
- 5
- 회전 가능 결합 수
- 7
- 무거운 원자 수
- 26
- 형식 전하
- 0
- 복잡도
- 497
물리화학적 성질
- 끓는 점
- 541.2 · 541.2±60.0 °C(Predicted)
- 밀도
- 1.16 · 1.16±0.1 g/cm3(Predicted)
- 산도 계수 (pKa)
- 3.56 · 3.56±0.20(Predicted)
화학 및 산업
약리 정보
MeSH Pharmacological Classification
Drugs used to prevent SEIZURES or reduce their severity.
Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects.
Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS.
공급사3 곳
上海陶术生物科技股份有限公司13564774135 · [email protected]
TargetMol中国（陶术生物）15002134094 · [email protected]
上海阿摩尔生物科技有限公司13370042665 18916960931 · [email protected]
관련 반응
0건
현재 필터 조건에 해당하는 반응 기록이 없습니다.
화합물 노트
불러오는 중…